Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Funding discrepancies, halted children's study & pot: NIH grilled

This article was originally published in Scrip

Executive Summary

As Capitol Hill budget hearings tend to go, it was a free-for-all at the 3 March House hearing of the Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies where top officials from the National Institutes of Health (NIH) were grilled on everything from why the agency halted the congressionally authorized National Children's Study to the legalization of marijuana.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC027984

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel